Professor Andrew Westwell - Porth Ymchwil - Ffurfwedd Safonol Converis

Ewch i'r Pennawd Ewch i'r Dudalen Lywio Ewch i'r Cynnwys Ewch i'r Troednodyn

Rhestr o bobl » Professor Andrew Westwell

Professor Andrew Westwell

Prosiectau fel Prif Ymchwiliwr

null

null

1 o 3

null

null

Synthetic routes of 18F labelled gemicitabine and related 2"-fluoronucleotides - Cyllidwr:Cancer Research Wales (01.10.2011 - 30.09.2014)

Discovery of novel site-specific FAK inhibitors for potential treatment of metastatic breast cancer - Cyllidwr:Welsh Government, - Cyllidwr:HEFCW (01.01.2015 - 31.12.2015)

Cancer drug discovery: Targeting protein - protein interactions - Cyllidwr:Universiti Putra Malaysia (01.10.2007 - 01.10.2010)

Inhibitors of aB-crystallin (CRYAB) for the treatment of triple-negative breast cancer - Cyllidwr:Cancer Research Wales (01.09.2014 - 31.12.2016)

Advancing analogues of a novel cFlip inhibitor which sensitises breast cancer cells and stem cells to TRAIL - Cyllidwr:Welsh Government, - Cyllidwr:HEFCW (01.10.2015 - 30.09.2016)

Prosiectau fel Cyd-Ymchwiliwr

null

null

1 o 5

null

null

Sensitizing to radiotherapy: Pre clinical evaluation of a novel indication for adjuvant Bcl3i - Cyllidwr:Welsh Government, - Cyllidwr:HEFCW (01.10.2015 - 31.12.2016)

The identification and selection of candidate lead compounds against BCL3 - Cyllidwr:BioVitas Capital Ltd, - Cyllidwr:Tiziana Pharma Ltd (01.11.2013 - 13.10.2017)

Inducing tyrosine kinase receptor degradation as a novel therapeutic strategy in breast cancer - Cyllidwr:Cancer Research Wales (01.10.2010 - 31.12.2014)

Design and synthesis of molecular inhibitors of c-FLIP activity as a therapeutic strategy to target breast cancer stem cells - Cyllidwr:Cancer Research Wales (01.10.2012 - 30.09.2015)

Inducing HER2 endocytosis and down regulation via enhanced antibody-receptor clustering as a therapeutic strategy in breast cancer - Cyllidwr:Cancer Research Wales (21.09.2015 - 31.08.2017)

Diweddarwyd y tro diwethaf ar 2020-29-03 am 04:05